Skip to content Skip to footer
U.S. stocks finished Monday sharply lower, with the Nasdaq Composite falling 2.49%, the S&P 500 losing 1.92% and the Dow Jones Industrial Average declining 739.38 points. The markets realized losses across large-cap and small-cap shares, while the Cboe Volatility Index jumped 22.06%…
AlloSure Kidney Data Excites, Dupixent Sales Surge and POTENTIAL Competitor, EP-104GI, Nears December EoE Catalyst Biotechnology’s most persuasive growth stories are moving beyond laboratory promise and into financial statements, clinical evidence and approaching trial milestones. CareDx (NASDAQ: CDNA) reported third-quarter revenue growth…
Better biomarkers, new FDA approvals and an emerging delivery pipeline strengthen the case for Parkinson’s innovation, with AbbVie and Serina Therapeutics offering distinct investment angles. The most compelling Parkinson’s investment story does not begin with a stock chart. It begins with a…